Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single‐arm, prospective phase 2 study
出版年份 2021 全文链接
标题
Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single‐arm, prospective phase 2 study
作者
关键词
-
出版物
CANCER
Volume 127, Issue 17, Pages 3163-3171
出版商
Wiley
发表日期
2021-05-28
DOI
10.1002/cncr.33626
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort
- (2019) Rongrong Yang et al. DIABETOLOGIA
- Nasopharyngeal carcinoma
- (2019) Yu-Pei Chen et al. LANCET
- Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
- (2018) Edwin P. Hui et al. CLINICAL CANCER RESEARCH
- Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
- (2018) Yu-Pei Chen et al. CLINICAL CANCER RESEARCH
- NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
- (2018) A. Dimitrios Colevas et al. Journal of the National Comprehensive Cancer Network
- Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
- (2018) Xin-Ran Tang et al. LANCET ONCOLOGY
- Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial
- (2018) M Staehler et al. ANNALS OF ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial
- (2018) M Gross-Goupil et al. ANNALS OF ONCOLOGY
- Sorafenib for Advanced and Refractory Desmoid Tumors
- (2018) Mrinal M. Gounder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment
- (2017) Xiong Zou et al. EUROPEAN JOURNAL OF CANCER
- Blood Pressure Trajectories and the Risk of Intracerebral Hemorrhage and Cerebral InfarctionNovelty and Significance
- (2017) Weijuan Li et al. HYPERTENSION
- Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma
- (2017) Qiu-Xia Peng et al. Oncotarget
- Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy
- (2016) Jian Ji Pan et al. CANCER
- Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
- (2016) Li Zhang et al. LANCET
- Nasopharyngeal carcinoma
- (2016) Melvin L K Chua et al. LANCET
- Ten years of anti-vascular endothelial growth factor therapy
- (2016) Napoleone Ferrara et al. NATURE REVIEWS DRUG DISCOVERY
- Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
- (2015) Anne W.M. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyperlipidemia Attenuates Vascular Endothelial Growth Factor–Induced Angiogenesis, Impairs Cerebral Blood Flow, and Disturbs Stroke Recovery via Decreased Pericyte Coverage of Brain Endothelial Cells
- (2013) Anil Zechariah et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial
- (2013) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma†
- (2012) C. Xue et al. ANNALS OF ONCOLOGY
- Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma
- (2012) Ying Jin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
- (2011) E. P. Hui et al. ANNALS OF ONCOLOGY
- YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
- (2011) Shu Tian et al. CANCER SCIENCE
- A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
- (2011) Wan-Teck Lim et al. CLINICAL CANCER RESEARCH
- A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer
- (2009) George Fountzilas et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II study of sunitinib malate in head and neck squamous cell carcinoma
- (2009) Nicholas W. Choong et al. INVESTIGATIONAL NEW DRUGS
- Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01
- (2009) Jean-Pascal H. Machiels et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
- (2009) Youjin Je et al. LANCET ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Bowel Perforation After Radiotherapy in a Patient Receiving Sorafenib
- (2008) Natascha A.J.B. Peters et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now